4521: 科研製薬 | 貸借残高(日証協公表)

報告日貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比新規貸付成約高前週比新規借入成約高(自己)前週比新規借入成約高(転貸)前週比
2025-10-17(金)663,088+135,41257,735-9,300360,106-31,477474,576+115,4668,067-34,62153,223-45,503
2025-10-10(金)527,676+241,21667,035-113,630391,583-31,895359,110+218,26942,688-61,01298,726-132,419
2025-10-03(金)286,460+45,138180,665-95,184423,478+103,916140,841+39,872103,700+3,130231,145+8,231
2025-09-26(金)241,322-202,938275,849+200,114319,562+138,490100,969-18,421100,570-183,331222,914+209,509
2025-09-19(金)444,260-13775,735+29,400181,072-1,900119,390-132,264283,901+258,17913,405-50,344
2025-09-12(金)444,397+7,13446,335-9,200182,972-14,388251,654+60,00325,722+11,11863,749+35,460
2025-09-05(金)437,263-11,30555,535+5,900197,360-4,310191,651-72,65114,604+4,80428,289-8,013
2025-08-29(金)448,568-58,95349,635-1,500201,670-2,622264,302-47,1379,800+2,40036,302+26,202
2025-08-22(金)507,521-7,40051,135-400204,292+8,100311,439-81,3767,400+99510,100-61,310
2025-08-15(金)514,921+42,74351,535-23,200196,192+22,563392,815+199,9196,405+1,93771,410+44,202
2025-08-08(金)472,178-33,15874,735+4,523173,629-19,853192,896+66,5924,468-8,74027,208+3,688
2025-08-01(金)505,336-47,38570,212-2,229193,482+3,332126,304-10,12213,208+7,59223,520-16,980
2025-07-25(金)552,721-62,00072,441+6,300190,150-40,926136,426-179,5825,616+5,31640,500+14,508
2025-07-18(金)614,721+84,40066,141-2,494231,076+5,334316,008+76,393300-1,61425,992+1,892
2025-07-11(金)530,321-58,18468,635+4,500225,742-43,540239,615-1,0491,914-15,35624,100+10,160
2025-07-04(金)588,505+13,61864,135-5,700269,282-9,486240,664+41,46717,270+4,97613,940-4,061
2025-06-27(金)574,887+58,81569,835+1,600278,768+22,285199,197-18,64512,294-96418,001-1,133
2025-06-20(金)516,072-84,47868,235+100256,483-52,174217,842+42,06913,258-60,33219,134-16,067
2025-06-13(金)600,550-93,16168,135+9,000308,657-41,591175,773-132,51173,590+14,65635,201-118,464
2025-06-06(金)693,711-19,19259,135-1,900350,248+67,998308,284+135,04058,934+4,324153,665+43,765